Galapagos NV
GLPG
#4563
Rank
S$2.73 B
Marketcap
S$40.94
Share price
-0.57%
Change (1 day)
13.09%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : S$3.72 Billion

According to Galapagos NV's latest financial reports the company has S$3.72 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$4.09 B0.4%
2023-12-31$S$4.08 B12.36%
2022-12-31$S$3.63 B-10.24%
2021-12-31$S$4.04 B-6.86%
2020-12-31$S$4.34 B0.05%
2019-12-31$S$4.34 B128.86%
2018-12-31$S$1.89 B16.85%
2017-12-31$S$1.62 B40.61%
2016-12-31$S$1.15 B104.6%
2015-12-31$S$0.56 B70.42%
2014-12-31$S$0.33 B13.28%
2013-12-31$S$0.29 B52.63%
2012-12-31$S$0.19 B-3.76%
2011-12-31$S$0.19 B-21.76%
2010-12-31$S$0.25 B16.19%
2009-12-31$S$0.21 B29.9%
2008-12-31$S$0.16 B-18.64%
2007-12-31$S$0.20 B-6.5%
2006-12-31$S$0.22 B83.81%
2005-12-31$S$0.12 B425.59%
2004-12-31$S$22.94 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
S$59.57 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$102.73 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$111.83 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-S$3.37 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$48.44 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$66.43 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$9.40 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$27.44 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$67.26 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA